The Conversation: Social norms stop Ethiopian girls from making safe choices about pregnancy
Kate Pincock, research associate at the University of Oxford, and Nicola Jones, research fellow at the Overseas Development Institute (2/24).

Devex: Opinion: Data science — the new normal in public health management
John Sargent, co-founder of BroadReach (2/26).

The Guardian: Women can be protected from cervical cancer — so why aren’t we doing it?
Nelly R. Mugo, chief research officer at Kenya Medical Research Institute (2/24).

The Hill: What if it were you? Fighting the ‘globalization of indifference’ on the refugee crisis
Michel Landry, professor of orthopedic surgery and global health at Duke University (2/23).

Inter Press Service: SDGs Corporate Tracker to Monitor Progress of U.N.’s Development Agenda
Peter Paul van de Wijs, chief external affairs officer at the Global Reporting Initiative (GRI) (2/21).

Orlando Sentinel: Vaccines in developing countries save U.S. lives | Commentary
Banke Aluko, student at UCF and volunteer with the ONE Campaign (2/21).

STAT: Will the newest pill for HIV prevention fuel progress — or profits?
Douglas Krakower, infectious disease physician and assistant professor of medicine at Harvard Medical School; Kenneth Katz, dermatologist at Kaiser Permanente San Francisco Medical Center; and Julia L. Marcus, infectious disease epidemiologist and assistant professor of population medicine at Harvard Medical School (2/26).

Thomson Reuters Foundation: Opinion: The opportunity to end the HIV epidemic is in our grasp — but no one knows about it
Ian Green, chief executive of Terrence Higgins Trust, and Deborah Gold, chief executive of National AIDS Trust (2/21).